» Articles » PMID: 30654638

Transplanting Cells for Spinal Cord Repair: Who, What, When, Where and Why?

Overview
Journal Cell Transplant
Date 2019 Jan 19
PMID 30654638
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular transplantation for repair of the injured spinal cord has a rich history with strategies focused on neuroprotection, immunomodulation, and neural reconstruction. The goal of the present review is to provide a concise overview and discussion of five key themes that have become important considerations for rebuilding functional neural networks. The questions raised include: (i) who are the donor cells selected for transplantation, (ii) what is the intended target for repair, (iii) when is the optimal time for transplantation, (iv) where should the cells be delivered, and lastly (v) why does cell transplantation remain an attractive candidate for promoting neural repair after injury? Recent developments in neurobiology and engineering now enable us to start addressing these questions with multidisciplinary expertise and methods.

Citing Articles

Bibliometric analysis of stem cells for spinal cord injury: current status and emerging frontiers.

Shang Z, Wanyan P, Wang M, Zhang B, Cui X, Wang X Front Pharmacol. 2023; 14:1235324.

PMID: 37533634 PMC: 10392836. DOI: 10.3389/fphar.2023.1235324.


Therapeutic Strategies Targeting Respiratory Recovery after Spinal Cord Injury: From Preclinical Development to Clinical Translation.

Michel-Flutot P, Lane M, Lepore A, Vinit S Cells. 2023; 12(11).

PMID: 37296640 PMC: 10252981. DOI: 10.3390/cells12111519.


Cell transplantation to repair the injured spinal cord.

Hall A, Fortino T, Spruance V, Niceforo A, Harrop J, Phelps P Int Rev Neurobiol. 2022; 166:79-158.

PMID: 36424097 PMC: 10008620. DOI: 10.1016/bs.irn.2022.09.008.


Diseased, differentiated and difficult: Strategies for improved engineering of neurological systems.

Elder N, Fattahi F, McDevitt T, Zholudeva L Front Cell Neurosci. 2022; 16:962103.

PMID: 36238834 PMC: 9550918. DOI: 10.3389/fncel.2022.962103.


Mesenchymal Stromal Cell Therapy in Spinal Cord Injury: Mechanisms and Prospects.

Xie J, Wang X, Li M, Tao Z, Teng W, Saijilafu Front Cell Neurosci. 2022; 16:862673.

PMID: 35722621 PMC: 9204037. DOI: 10.3389/fncel.2022.862673.


References
1.
Snyder E, Yoon C, Flax J, Macklis J . Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc Natl Acad Sci U S A. 1997; 94(21):11663-8. PMC: 23575. DOI: 10.1073/pnas.94.21.11663. View

2.
Bonner J, Haas C, Fischer I . Preparation of neural stem cells and progenitors: neuronal production and grafting applications. Methods Mol Biol. 2013; 1078:65-88. DOI: 10.1007/978-1-62703-640-5_7. View

3.
Priest C, Manley N, Denham J, Wirth 3rd E, Lebkowski J . Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. Regen Med. 2015; 10(8):939-58. DOI: 10.2217/rme.15.57. View

4.
Li K, Javed E, Scura D, Hala T, Seetharam S, Falnikar A . Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury. Exp Neurol. 2015; 271:479-92. PMC: 4586993. DOI: 10.1016/j.expneurol.2015.07.020. View

5.
Orsal D, Yakovleff A, Gimenez y Ribotta M, Privat A . Recovery of locomotor activity in the adult chronic spinal rat after sublesional transplantation of embryonic nervous cells: specific role of serotonergic neurons. Exp Brain Res. 1997; 113(3):443-54. DOI: 10.1007/pl00005597. View